1. Home >
  2. M&A >
  3. Divestiture >
  4. Austria >
  5. Scantox Acquires Scantox Neuro

M&A Deal Summary

Scantox Acquires Scantox Neuro

On November 30, 2023, Scantox acquired life science company Scantox Neuro from QPS

Acquisition Highlights
  • This is Scantox’s 1st transaction in the Life Science sector.
  • This is Scantox’s 1st transaction in Austria.

M&A Deal Summary
Date 2023-11-30
Target Scantox Neuro
Sector Life Science
Buyer(s) Scantox
Sellers(s) QPS
Deal Type Divestiture

Target

Scantox Neuro

Grambach, Austria
Scantox Neuro specializes in neurodegenerative, rare diseases and mental disorders. Scantox Neuro was founded in 1999 and is based in Grambach, Austria.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Scantox

Lille Skensved, Denmark
Category Company
Founded 1977
Sector Life Science
Employees70
Revenue 109M DKK (2019)
DESCRIPTION

Scantox is a GLP (“Good Laboratory Practice”) accredited CRO, providing pre-clinical research services, including regulatory in-vivo toxicology studies, that are critical to any drug development process. Scantox was founded in 1977 and is based in Lille Skensved, Denmark.

DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Divestiture M&A Deals 1 of 1
Country: Austria M&A 1 of 1
Year: 2023 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-09-09 Gentronix

Cheshire, United Kingdom

Gentronix is a biotechnology company helping to accelerate the pace of drug discovery in the pharmaceutical industry. Its first product, called GreenScreen, is a novel pre-regulatory screening assay for use at the hits-to-lead and early lead optimization stages of the drug discovery process. GreenScreen is based in Cheshire, United Kingdom.

Buy -

Seller(S) 1

SELLER

QPS

Newark, Delaware, United States
Category Company
Founded 1995
Sector Life Science
DESCRIPTION

QPS provides GLP/GCP-compliant preclinical and clinical research services to pharmaceutical and biotechnology clients worldwide in the areas of Bioanalysis, Drug Metabolism and Pharmacokinetics, Toxicology, Translational Medicine, and Clinical Research. QPS was established in 1995 and is based in Newark, Delaware.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 2 of 2
Country: Austria M&A 1 of 1
Year: 2023 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-24 Xendo BV

Leiden, Netherlands

Xendo BV is an independent consultancy and project management organisation in the fields of pharmaceutical products, medical devices and healthcare. Xendo BV was founded in 1990 and is based in Leiden, Netherlands.

Sell -
Mergr

Solution for

Product

Company

Legal